文献速递生殖医学产科

HLA-F基因位点变异与生育治疗后妊娠成功及受孕时间相关

Variation in the HLA-F gene locus with functional impact is associated with pregnancy success and time-to-pregnancy after fertility treatment.
PubMed 文献 · Hum Reprod · 2020-01-01

本研究纳入接受辅助生殖技术(ART)治疗的102例女性和91例男性,以及78例自然受孕的生育力正常女性对照,对HLA-F基因位点三个单核苷酸多态性(SNP)进行基因分型。结果显示,与中黄体期子宫内膜HLA-F mRNA低表达相关的基因型携带者,达到妊娠和活产所需的生育治疗周期数更多。

要点

  • HLA-F rs1362126 AA基因型女性比GG基因型平均多需2.1个治疗周期达到妊娠。
  • rs2523405 GG基因型比TT基因型多需1.8个周期,rs2523393 GG比AA多需2.2个周期。
  • 生育力正常对照与不孕女性间三个SNP的基因型和等位基因分布无显著差异。

核心结论

  • HLA-F SNP基因型和HLA-F双倍型与达到妊娠和活产所需的生育治疗周期数相关。

研究设计与样本

  • 研究纳入2009至2014年间在大学医院生育门诊招募的102例接受ART治疗的女性和91例男性,以及2017至2018年间招募的78例自然受孕的生育力正常女性对照。
  • 对血液样本基因组DNA进行Sanger测序,检测HLA-F基因位点三个SNP:rs1362126(G/A)、rs2523405(T/G)和rs2523393(A/G)。

主要发现

  • 生育力正常女性对照与不孕女性组之间,三个HLA-F SNP的基因型和等位基因分布无显著差异。
  • 在ART组女性中,携带与中黄体期子宫内膜HLA-F mRNA低表达相关的基因型者,以治疗周期数衡量的受孕时间显著更长。
  • rs1362126 AA相对于GG的OR为0.30(95%CI=0.10-0.87,P=0.02);rs2523405 GG相对于TT的OR为0.40(95%CI=0.15-1.04,P=0.06);rs2523393 GG相对于AA的OR为0.27(95%CI=0.09-0.78,P=0.01)。
  • 趋势检验中,rs1362126每个A等位基因OR为0.56(95%CI=0.35-0.89,P=0.01);rs2523405每个G等位基因OR为0.65(95%CI=0.42-1.00,P=0.05);rs2523393每个G等位基因OR为0.56(95%CI=0.36-0.86,P=0.01)。
  • 在前八个治疗周期内,rs1362126 AA基因型女性比GG基因型平均多需2.1个周期达到妊娠,rs2523405 GG比TT多需1.8个周期,rs2523393 GG比AA多需2.2个周期。

关键数值与推荐

  • 调整BMI、女性年龄、IVF(每周期是/否)、ICSI(每周期是/否)、女性因素(是/否)和男性因素(是/否)后,基因型与受孕时间的关联仍显著且几乎不变。

临床怎么用

  • 对于接受ART治疗的不孕女性,HLA-F基因位点SNP分型可能有助于预估达到妊娠所需的治疗周期数。

局限性

  • ART具体类型从治疗开始即已选定,仅因一线治疗方案不同,女性达到妊娠的机会可能存在差异;但多因素分析已对ART类型进行了调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: The aim of this study was to investigate a possible influence of three single nucleotide polymorphisms (SNPs) in the HLA-F gene locus on time-to-pregnancy and pregnancy success after fertility treatment. SUMMARY ANSWER: HLA-F SNP genotypes and HLA-F diplotypes are associated with the number of fertility treatment cycles needed to achieve pregnancy and live birth. WHAT IS KNOWN ALREADY: HLA class Ib molecules, including HLA-F, which are known to be expressed by extra-villous trophoblast cells have immunomodulatory properties and play a role at the feto-maternal interface. However, a few recent studies suggest that HLA-F expressed in the mid-luteal endometrium may play a part in the establishment of pregnancy as well. Three genetic polymorphisms in the HLA-F gene locus influence the expression of HLA-F in the mid-luteal endometrium and are associated with time-to-pregnancy in healthy women. STUDY DESIGN, SIZE, DURATION: The current study included 102 female patients and 91 male patients attending for ART treatment and recruited between 2009 and 2014 at fertility clinics in a University Hospital setting, and 78 fertile female controls recruited in 2017 and 2018 at a department of Obstetrics and Gynaecology in a University Hospital. All women in the control group conceived naturally, and no other clinical data for the controls were retrieved. PARTICIPANTS/MATERIALS, SETTING, METHODS: Genotyping of genomic DNA from blood samples was performed with Sanger sequencing for the three SNPs of interest in the HLA-F gene locus: rs1362126 (G/A), rs2523405 (T/G) and rs2523393 (A/G). Furthermore, clinical data were collected for the couples in fertility treatment. MAIN RESULTS AND THE ROLE OF CHANCE: There were no significant differences in the distributions of the three HLA-F SNP genotypes and alleles between the female fertile control group and the female infertility group. We considered if the number of treatment cycles was related to the HLA-F SNP genotypes and HLA-F diplotypes in a discrete time to event analyses. A significant association with longer time-to-pregnancy, measured as number of fertility treatment cycles, was observed for women in the ART group who carried the HLA-F genotypes that are associated with a lower amount of HLA-F mRNA expressed in mid-luteal endometrium. For the rs1362126 AA genotype relative to the GG genotype, the odds ratio (OR) was 0.30 (95% CI = 0.10-0.87, P = 0.02); for the rs2523405 GG genotype relative to the TT genotype, the OR was 0.40 (95% CI = 0.15-1.04, P = 0.06); and for the rs2523393 GG genotype relative to the AA genotype, the OR was 0.27 (95% CI = 0.09-0.78, P = 0.01). In addition to comparing the HLA-F genotypes by a standard likelihood-ratio test, a trend test based on the number of G or A alleles were also performed. The HLA-F genotypes associated with longer time-to-pregnancy in these tests were as follows: number of A alleles at rs1362126 (P = 0.01), the OR was 0.56 per A allele (95% CI = 0.35-0.89); number of G alleles at rs2523405 (P = 0.05), OR was 0.65 per G allele (95% CI = 0.42-1.00); and number of G alleles at rs2523393 (P = 0.01), OR was 0.56 per G allele (95% CI = 0.36-0.86). On average, for the rs1362126 SNP, 2.1 more treatment cycles for a woman who carried the AA genotype were needed to achieve pregnancy within the first eight treatment cycles compared with a woman who carried the GG genotype. Likewise, for the rs2523405 SNP, 1.8 more cycles for the GG genotype compared with the TT genotype were needed, and for the rs2523393 SNP, 2.2 more treatment cycles for a woman who carried the GG genotype compared with a woman who carried the AA genotype were needed. Adjustments for the covariates BMI, female age, IVF (yes/no for each cycle), ICSI (yes/no for each cycle), female factor (yes/no) and male factor (yes/no), were also performed modeling the cycle-specific probabilities and the genotypes remained significant and almost unchanged. LIMITATIONS, REASONS FOR CAUTION: Specific types of ART will be chosen from the start of treatment, which means that the chances of achieving pregnancy could differ between the women solely due to their first line of treatment. However, multivariate analyses are performed to adjust for type of ART treatment. WIDER IMPLICATIONS OF THE FINDINGS: To our knowledge, this is the first study that shows associations between, and implications of, HLA-F gene locus variation and time-to-pregnancy and pregnancy success in a clinical setting for fertility treatment/ART. STUDY FUNDING/COMPETING INTEREST(S): Supported by the Region Zealand Health Sciences Research foundation and by Zealand University Hospital through the ReproHealth Research Consortium ZUH. The authors declare no conflict of interest.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Langkilde CH, Nilsson LL, Jørgensen N, et al. Variation in the HLA-F gene locus with functional impact is associated with pregnancy success and time-to-pregnancy after fertility treatment. Hum Reprod. 2020. PMID: 32020202. doi:10.1093/humrep/dez276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。